TRUXIMA

This brand name is authorized in Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug TRUXIMA contains one active pharmaceutical ingredient (API):

1 Rituximab UNII 4F4X42SYQ6 - RITUXIMAB

Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas. Read about Rituximab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRUXIMA Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FA01	Rituximab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors
Discover more medicines within L01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10179R, 10193L, 10576P, 10583B, 10591K, 10593M, 11790M, 11800C, 11804G, 11805H, 11810N, 11813R, 11935E, 11936F, 4613T, 4614W, 4615X, 7257Y, 7258B, 7259C, 9544H, 9611W
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 545120040000407, 545120040000507
Country: CA	Health Products and Food Branch	Identifier(s): 02478382, 02478390
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 123-MBE-0218
Country: EE	Ravimiamet	Identifier(s): 1739448, 1770993
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1161167001, 1161167002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 175351, 418667
Country: FR	Base de données publique des médicaments	Identifier(s): 64102473, 64237955
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 341657, 346138
Country: HK	Department of Health Drug Office	Identifier(s): 66443, 66444
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8342, 8343
Country: IT	Agenzia del Farmaco	Identifier(s): 045266018, 045266020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1082365, 1085387
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 51004, 51012
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19626, 19647
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100387562, 100463050
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63707001, W63906001
Country: SG	Health Sciences Authority	Identifier(s): 15671P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680614140129, 8699862950244
Country: US	FDA, National Drug Code	Identifier(s): 63459-103, 63459-104